156 related articles for article (PubMed ID: 8585009)
1. Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture.
Lenich C; Pannell R; Gurewich V
Thromb Haemost; 1995 Aug; 74(2):698-703. PubMed ID: 8585009
[TBL] [Abstract][Full Text] [Related]
2. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
Reddigari SR; Shibayama Y; Brunnée T; Kaplan AP
J Biol Chem; 1993 Jun; 268(16):11982-7. PubMed ID: 8505323
[TBL] [Abstract][Full Text] [Related]
3. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.
Colman RW; Pixley RA; Najamunnisa S; Yan W; Wang J; Mazar A; McCrae KR
J Clin Invest; 1997 Sep; 100(6):1481-7. PubMed ID: 9294114
[TBL] [Abstract][Full Text] [Related]
4. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2017 Jul; 140(1):170-176. PubMed ID: 27826093
[TBL] [Abstract][Full Text] [Related]
5. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate.
Tsuda H; Miyata T; Iwanaga S; Yamamoto T
Thromb Haemost; 1992 Apr; 67(4):440-4. PubMed ID: 1631792
[TBL] [Abstract][Full Text] [Related]
6. [The so-called "contact" system of plasma: consequences of the activation of the Hageman factor].
Damas J; Adam A
Ann Biol Clin (Paris); 1988; 46(3):185-9. PubMed ID: 3044204
[TBL] [Abstract][Full Text] [Related]
7. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
Loza JP; Gurewich V; Johnstone M; Pannell R
Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800
[TBL] [Abstract][Full Text] [Related]
8. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
10. High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation.
Lin Y; Harris RB; Yan W; McCrae KR; Zhang H; Colman RW
Blood; 1997 Jul; 90(2):690-7. PubMed ID: 9226169
[TBL] [Abstract][Full Text] [Related]
11. Plasma contact activation: a revised hypothesis.
Schmaier AH
Biol Res; 1998; 31(3):251-62. PubMed ID: 9830513
[TBL] [Abstract][Full Text] [Related]
12. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
Fernando LP; Natesan S; Joseph K; Kaplan AP
Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis.
Hauert J; Nicoloso G; Schleuning WD; Bachmann F; Schapira M
Blood; 1989 Mar; 73(4):994-9. PubMed ID: 2465792
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional characterization of factor XII.
Tans G; Rosing J
Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
[TBL] [Abstract][Full Text] [Related]
15. Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix.
Motta G; Shariat-Madar Z; Mahdi F; Sampaio CA; Schmaier AH
Thromb Haemost; 2001 Sep; 86(3):840-7. PubMed ID: 11583317
[TBL] [Abstract][Full Text] [Related]
16. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor.
Kleniewski J; Donaldson VH
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):198-202. PubMed ID: 8419923
[TBL] [Abstract][Full Text] [Related]
18. Activation of the plasma kallikrein/kinin system on endothelial cells.
Rojkjaer R; Schmaier AH
Proc Assoc Am Physicians; 1999; 111(3):220-7. PubMed ID: 10354362
[TBL] [Abstract][Full Text] [Related]
19. Ethanol-induced increased surface-localized fibrinolytic activity in cultured human endothelial cells: kinetic analysis.
Abou-Agag LH; Tabengwa EM; Tresnak JA; Wheeler CG; Taylor KB; Booyse FM
Alcohol Clin Exp Res; 2001 Mar; 25(3):351-61. PubMed ID: 11290845
[TBL] [Abstract][Full Text] [Related]
20. Factor XIIa activation of plasminogen is enhanced by contact activating surfaces and Zn2+.
Schousboe I
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):97-104. PubMed ID: 9518051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
